These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8758473)

  • 61. Partial characterization of Chlamydia trachomatis isolates resistant to multiple antibiotics.
    Jones RB; Van der Pol B; Martin DH; Shepard MK
    J Infect Dis; 1990 Dec; 162(6):1309-15. PubMed ID: 2230260
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Rokitamycin in the treatment of female genital Chlamydia and Mycoplasma infections. Comparative study vs josamycin ].
    Colombo U; Pifarotti G; Amidani M; Viezzoli T; Pifarotti P
    Minerva Ginecol; 1998 Nov; 50(11):491-7. PubMed ID: 9882991
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vitro activities of temafloxacin (A-62254) and four other antibiotics against Chlamydia trachomatis.
    Segreti J; Kessler HA; Kapell KS; Trenholme GM
    Antimicrob Agents Chemother; 1989 Jan; 33(1):118-9. PubMed ID: 2712543
    [TBL] [Abstract][Full Text] [Related]  

  • 64. In-vitro anti-chlamydial activities of free and liposomal tetracycline and doxycycline.
    Sangare L; Morisset R; Ravaoarinoro M
    J Med Microbiol; 1999 Jul; 48(7):689-693. PubMed ID: 10403420
    [TBL] [Abstract][Full Text] [Related]  

  • 65. In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis.
    Walsh M; Kappus EW; Quinn TC
    Antimicrob Agents Chemother; 1987 May; 31(5):811-2. PubMed ID: 3038010
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evaluation of in vitro activity of rokitamycin against Chlamydia trachomatis].
    Bannai H; Miyano A; Miyazawa H; Ashihara Y
    Kansenshogaku Zasshi; 1990 Jun; 64(6):687-92. PubMed ID: 2401815
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Susceptibilities of Chlamydia trachomatis isolates causing uncomplicated female genital tract infections and pelvic inflammatory disease.
    Rice RJ; Bhullar V; Mitchell SH; Bullard J; Knapp JS
    Antimicrob Agents Chemother; 1995 Mar; 39(3):760-2. PubMed ID: 7793888
    [TBL] [Abstract][Full Text] [Related]  

  • 68. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.
    Chotikanatis K; Kohlhoff SA; Hammerschlag MR
    Antimicrob Agents Chemother; 2014; 58(3):1800-1. PubMed ID: 24366753
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Relative resistance to erythromycin in Chlamydia trachomatis.
    Mourad A; Sweet RL; Sugg N; Schachter J
    Antimicrob Agents Chemother; 1980 Nov; 18(5):696-8. PubMed ID: 7447426
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antichlamydial activity of ofloxacin.
    Hirai K; Une T
    Microbiol Immunol; 1986; 30(5):445-50. PubMed ID: 3462450
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis.
    Bowie WR; Lee CK; Alexander ER
    J Infect Dis; 1978 Nov; 138(5):655-9. PubMed ID: 712119
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Immunotropic activity of antimicrobial agents used in tuberculosis].
    Aleksandrova AE; Vinogradova TI
    Probl Tuberk; 1996; (2):43-5. PubMed ID: 8657696
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Bactericidal activity of ofloxacin against Mycobacterium kansasii].
    Tsukamura M
    Kekkaku; 1990 Nov; 65(11):719-21. PubMed ID: 2277465
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antimicrobial activity of several antibiotics and a sulfonamide against Chlamydia trachomatis organisms in cell culture.
    Kuo CC; Wang SP; Grayston JT
    Antimicrob Agents Chemother; 1977 Jul; 12(1):80-3. PubMed ID: 883821
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.
    Kimura M; Kishimoto T; Niki Y; Soejima R
    Antimicrob Agents Chemother; 1993 Apr; 37(4):801-3. PubMed ID: 8494377
    [TBL] [Abstract][Full Text] [Related]  

  • 76. In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation.
    Lee CK; Bowie WR; Alexander ER
    Antimicrob Agents Chemother; 1978 Mar; 13(3):441-5. PubMed ID: 162541
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Can various antibiotics be combined for treating salpingitis?].
    Orfila J; Haider F
    Rev Fr Gynecol Obstet; 1992 Mar; 87(3):117-9. PubMed ID: 1579795
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.
    Kohlhoff SA; Huband MD; Hammerschlag MR
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7595-6. PubMed ID: 25288086
    [TBL] [Abstract][Full Text] [Related]  

  • 79. In vitro analysis of the change in resistance of Chlamydia trachomatis under exposure to sub-MIC levofloxacin for a therapeutic term.
    Takahashi S; Hagiwara T; Shiga S; Takaoki Hirose T; Tsukamoto T
    Chemotherapy; 2000; 46(6):402-7. PubMed ID: 11053906
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Antimicrobial activity of U-70138F (paldimycin), roxithromycin (RU 965), and ofloxacin (ORF 18489) against Chlamydia trachomatis in cell culture.
    Stamm WE; Suchland R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):806-7. PubMed ID: 3467650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.